Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors

Front Pharmacol. 2022 Dec 7:13:1108252. doi: 10.3389/fphar.2022.1108252. eCollection 2022.

¹ CBIOS-Universidade Lusófona Research Center for Biosciences & Health Technologies, Lisbon, Portugal.
² Faculty of Pharmacy, Instituto de Investigação do Medicamento (iMed.ULisboa), University of Lisbon, Lisbon, Portugal.
³ Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, Patras, Greece.
⁴ Fine Chemical and Natural Products Laboratory, IRNASUS CONICET-UCC, School of Chemistry, Universidad Católica de Córdoba, Córdoba, Argentina.

No abstract available

Keywords: cancer therapy; multidrug resistant (MDR) tumors; phytochemicals; plant-derived compounds; synthetic derivatives.

Publication types